Aprogen Pharmaceuticals Inc (003060) — Cash Flow Reinvestment Rate
Aprogen Pharmaceuticals Inc (003060) has a Cash Flow Reinvestment Rate of 1.29x as of December 2022, reinvesting ₩870.30 Million (capex ₩591.03 Million plus investments ₩-279.27 Million) from operating cash flow of ₩676.93 Million. Explore 003060 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aprogen Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Aprogen Pharmaceuticals Inc across 7 annual periods. Also explore how large is Aprogen Pharmaceuticals Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year capital reinvestment analysis for Aprogen Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of Aprogen Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.12x | ₩54.55 Billion | ₩25.73 Billion | ₩1.55 Billion | ▼ -76.0% |
| 2020 | 8.84x | ₩71.48 Billion | ₩8.09 Billion | ₩976.29 Million | ▼ -85.4% |
| 2019 | 60.44x | ₩43.14 Billion | ₩713.73 Million | ₩2.13 Billion | ▲ +92.7% |
| 2018 | 31.37x | ₩41.77 Billion | ₩1.33 Billion | ₩1.01 Billion | ▼ -63.2% |
| 2016 | 85.22x | ₩38.35 Billion | ₩449.98 Million | ₩2.82 Billion | ▲ +733.9% |
| 2015 | 10.22x | ₩18.88 Billion | ₩1.85 Billion | ₩5.37 Billion | ▼ -79.4% |
| 2010 | 49.52x | ₩12.28 Billion | ₩247.92 Million | ₩12.28 Billion | — |